Visby Medical’s over the counter (OTC) combination PCR test for Covid-19 and influenza A/B detection has secured US Food and Drug Administration (FDA) clearance, providing patients with an at-home test designed to detect the respiratory viruses earlier.

The California-based company’s multi-viral Visby Medical Flu and Covid-19 test yields results in 30 minutes. PCR testing is generally considered higher power compared to rapid antigen tests, though the latter became a popular detection method during the Covid-19 pandemic due to their accessibility. PCRs have traditionally required lab processing, making Visby’s at-home, rapid platform an important advancement for viral testing.